More on ABCL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-41.7% Growth)
- Ratings (9.2 Score)
- Holders

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

AbCellera (NQ:ABCL)
Delayed: 6.47 +0.31 (5.03%)
Prev. Close $6.16  
Open$6.04 
52 Wk High$ 
52 Wk Low$ 
Day High$6.55 
Day Low$5.95 
P/E N/A  
EPS$ 
Volume4,228,874 

Friends, Peers and Foes (?): JAZZ, ABSI, CERT, DOCS, HNGE (more...)

Jul 17, 2026 09:55 AM Cantor Fitzgerald Reiterates Overweight Rating on AbCellera Biologics (ABCL)
Jul 7, 2026 04:05 PM AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026
Jul 7, 2026 06:16 AM Benchmark Upgrades AbCellera Biologics (ABCL) to Buy
Jul 6, 2026 06:21 PM Form 4 AbCellera Biologics Inc. For: Jul 01 Filed by: Seely Lynn
Jul 6, 2026 06:15 PM Form 3 AbCellera Biologics Inc. For: Jun 30 Filed by: Seely Lynn
Jul 6, 2026 06:05 PM Form 4 AbCellera Biologics Inc. For: Jul 01 Filed by: Sandor Victor
Jul 6, 2026 02:54 PM Form 8-K AbCellera Biologics Inc. For: Jun 30
Jul 6, 2026 09:00 AM AbCellera adds Lynn Seely to its board of directors
Jul 6, 2026 09:00 AM AbCellera Appoints Dr. Lynn Seely to its Board of Directors
Jun 17, 2026 12:38 PM Form 8-K AbCellera Biologics Inc. For: Jun 17
View All Articles

Entities mentioned with ABCL

View All Entities